-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BiUT4WtII09XpsAElUqsLoJEIrNLyL5rGtN8cebYFGBr7cwnpGbLMYkRa8SZPyUQ JSnv+14FQPqwZMFVj5fnRQ== 0000947871-02-001504.txt : 20020731 0000947871-02-001504.hdr.sgml : 20020731 20020731095416 ACCESSION NUMBER: 0000947871-02-001504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020730 FILED AS OF DATE: 20020731 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 02715413 BUSINESS ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6504625900 MAIL ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 COMPANY DATA: COMPANY CONFORMED NAME: ORBIMED CAPITAL LLC CENTRAL INDEX KEY: 0001157524 OWNER IRS NUMBER: 134133323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2127396400 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 4 1 form4_073002capital.txt FORM 4 - CAPITAL - DEPOMED (JULY)
- ---------------- U.S. SECURITIES AND EXCHANGE COMMISSION ---------------------------- |F O R M 4| WASHINGTON, D.C. 20549 | OMB APPROVAL | - ---------------- |--------------------------| [ ] Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP |OMB Number 3235-0287| subject to Section 16. Form 4 |Expires: December 31, 2001| or Form 5 obligations may |Estimated average burden | continue. See Instruction 1(b). |hours per response.....0.5| ---------------------------- Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) - ------------------------------------------------------------------------------------------------------------------------------------ |1. Name and Address of Reporting Person*|2. Issuer Name and Ticker or Trading Symbol |6. Relationship of Reporting Persons to | | | | Issuer (Check all applicable) | | OrbiMed Advisors LLC (1) | Depomed, Inc. (DMI) | | | | | Director X 10% Owner | |----------------------------------------|------------------------------------------------|--- --- | | (Last) (First) (Middle) |3. IRS or Social |4. Statement for Month/ | Officer Other | | | Security Number of | Year |---(give title below) ---(specify below)| | | Reporting Person | | | | 767 Third Avenue, 30th Floor | (Voluntary) | | | | | | July 2002 | ------------------------------- | |----------------------------------------| |------------------------|----------------------------------------| | (Street) | |5. If Amendment, Date of|7. Individual or Joint/Group Filing | | | | Original (Month/Year)| (Check Applicable Line) | | | | | | | | | | Form filed by One Reporting Person | | | | |--- | | | | | X Form filed by More than One | | New York NY 10010 | | |--- Reporting Person | |----------------------------------------------------------------------------------------------------------------------------------| | (City) (State) (Zip) | | TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |----------------------------------------------------------------------------------------------------------------------------------| |1. Title of Security |2. Transac- |3. Trans- |4. Security Acquired (A) or |5. Amount of |6. Owner- |7. Nature of | | (Instr. 3) | tion Date| action | Disposed of (D) | Securities | ship Form:| Indirect | | |(Month/Day/ | Code | (Instr. 3, 4 and 5) | Beneficially | Direct (D)| Beneficial | | |Year) | (Instr. 8)| | Owned at End of| or | Ownership | | | |-------------|-------------------------------| Month | Indirect | (Instr.4) | | | | Code | V | Amount |(A) or | | (Instr. 3 and | (I) | | | | | | | |(D) |Price | 4) | (Instr. 4)| | |------------------------|------------|-------------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | Common Stock | 07/11/02 | S | | 13,276 | D |$3.36 | 1,890,050 | I(2) | | |------------------------|------------|------|------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | | | | | | | | | | | |------------------------|------------|-------------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | | | | | | | | | | | |------------------------|------------|-------------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | | | | | | | | | | | |------------------------|------------|-------------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | | | | | | | | | | | |------------------------|------------|-------------|----------------|-------|------|-----------------|------------|---------------| | | | | | | | | | | | | | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) * If the form is filed by more than one reporting person, see Instruction 4(b)(v) Page 1 Page 1 of 2 Pages
FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - ------------------------------------------------------------------------------------------------------------------------------------ |1. Title |2. Con- |3. |4. Trans-|5. Number of |6. Date |7. Title and |8. Price |9. Number |10. Owner-|11. | |of |version |Trans- | action| Derivative |Exercisable| Amount |of | of |ship Form |Nature | |Derivative|or |action | Code | Securities |and | of Underlying |Derivative|Derivative|of Deriv- |of | |Security |Exercise|Date |(Instr.8)| Acquired (A) or |Expiration | Securities) |Security |Securities|ative |Indirect | |(Instr. 3)|Price of|(Month/| | Disposed of (D) |Date | (Instr. 3 and |(Instr. 5)|Benefi- |Security: |Benefi- | | |Deriva- | Day/ | | (Instr. 3, 4 and |(Month/Day/| 4) | |cially |Direct |cial | | |tive |Year) | | 5) | Year) | | |Owned at |(D) or |Ownership| | |Security| | | |-----------|-----------------| |End of |Indirect |(Instr. | | | | | | |Date |Expi-| | | |Month |(I) |4) | | | | |---------|-------------------|Exer-|ra- | |Amount or| |(Instr. 4)|(Instr. | | | | | | | | | |cis- ltion | |Number of| | |4) | | | | | |Code | V | (A) | (D) |able lDate | Title |Shares | | | | | |----------|--------|-------|-----|---|----------|--------|-----|-----|-------|---------|----------|----------|----------|---------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |----------|--------|-------|-----|---|----------|--------|-----|-----|-------|---------|----------|----------|----------|---------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |----------|--------|-------|-----|---|----------|--------|-----|-----|-------|---------|----------|----------|----------|---------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: (1) Joint filing with OrbiMed Advisors LLC, OrbiMed Capital LLC and Samuel D. Isaly (3) of the same address. (2) Orbimed Advisors LLC, OrbiMed Capital LLC and OrbiMed Advisers Inc. have investment management discretion over a number of collective investment funds investing in Depomed, Inc. stock. The reporting persons have no beneficial interest in the securities pursuant to Rule 16a-1(2). (3) OrbiMed Advisors Inc. is 100% owned by Samuel D. Isaly who also has a controlling interest in OrbiMed Advisors LLC and OrbiMed Capital LLC. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ Samuel D. Isaly 7/20/02 ------------------------------- ---------------- **Signature of Reporting Person Date Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collections of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 SEC 1474 (3-99) Page 2 of 2 Pages
-----END PRIVACY-ENHANCED MESSAGE-----